Exequiel E Barrera - JoVE Visualize

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

Journal of Molecular Modeling|August 12, 2017

Modeling DMPC lipid membranes with SIRAH force-fieldExequiel E Barrera, Ezequiel N Frigini, Rodolfo D Porasso, et al.

International Journal of Molecular Sciences|December 17, 2024

Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and PrionopathiesOndrej Cehlar, Stefana Njemoga, Marian Horvath, et al.

Journal of Chemical Theory and Computation|February 28, 2019

The SIRAH 2.0 Force Field: Altius, Fortius, CitiusMatías R Machado, Exequiel E Barrera, Florencia Klein, et al.

Proteins|August 20, 2021

Evolutionary and structural constraints influencing apolipoprotein A-I amyloid behaviorRomina A Gisonno, Tomas Masson, Nahuel A Ramella, et al.

International Journal of Biological Macromolecules|April 19, 2026

Gradual N-terminal truncation of tau dGAE (297-391) reveals the importance of 321-325 sequence for early steps of fibril formationStefana Njemoga, Petra Majerova, Juraj Piestansky, et al.

Current Protein & Peptide Science|November 3, 2015

Pentameric models as alternative molecular targets for the design of new antiaggregant agentsExequiel E Barrera Guisasola, Lucas J Gutierrez, Sebastián A Andujar, et al.

European Journal of Medicinal Chemistry|March 26, 2015

New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug designExequiel E Barrera Guisasola, Sebastián A Andujar, Ellen Hubin, et al.

Bioorganic Chemistry|August 26, 2018

Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β42 monomerJános Gera, Titanilla Szögi, Zsolt Bozsó, et al.

Biotechnology Reports (Amsterdam, Netherlands)|January 29, 2026

Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint DiseaseValentina Varela, Monique Costa, Cecilia Maciel, et al.

Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

Journal of Molecular Modeling|August 12, 2017

Modeling DMPC lipid membranes with SIRAH force-fieldExequiel E Barrera, Ezequiel N Frigini, Rodolfo D Porasso, et al.

International Journal of Molecular Sciences|December 17, 2024

Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and PrionopathiesOndrej Cehlar, Stefana Njemoga, Marian Horvath, et al.

Journal of Chemical Theory and Computation|February 28, 2019

The SIRAH 2.0 Force Field: Altius, Fortius, CitiusMatías R Machado, Exequiel E Barrera, Florencia Klein, et al.

Proteins|August 20, 2021

Evolutionary and structural constraints influencing apolipoprotein A-I amyloid behaviorRomina A Gisonno, Tomas Masson, Nahuel A Ramella, et al.

International Journal of Biological Macromolecules|April 19, 2026

Gradual N-terminal truncation of tau dGAE (297-391) reveals the importance of 321-325 sequence for early steps of fibril formationStefana Njemoga, Petra Majerova, Juraj Piestansky, et al.

Current Protein & Peptide Science|November 3, 2015

Pentameric models as alternative molecular targets for the design of new antiaggregant agentsExequiel E Barrera Guisasola, Lucas J Gutierrez, Sebastián A Andujar, et al.

European Journal of Medicinal Chemistry|March 26, 2015

New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug designExequiel E Barrera Guisasola, Sebastián A Andujar, Ellen Hubin, et al.

Bioorganic Chemistry|August 26, 2018

Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β42 monomerJános Gera, Titanilla Szögi, Zsolt Bozsó, et al.

Biotechnology Reports (Amsterdam, Netherlands)|January 29, 2026

Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint DiseaseValentina Varela, Monique Costa, Cecilia Maciel, et al.

Pageof 2